IGF-1 LR3
Long R3 IGF-I / LR3 IGF-1
- Peptide length
- 83 amino acids
N-terminally extended protein analog
Open the sources to check how the studies were done and what they can support.
A modified IGF-I analog used in experimental growth-factor research, with altered interactions relative to native IGF-I.
- Family
- IGF-I analog
- Research target
- IGF-1 receptor pathway
- Molecular form
- N-terminally extended protein analog
What to know about the research
Laboratory growth and binding results are not human performance evidence. Mecasermin product evidence cannot be assigned to LR3.
Check the exact compound
Confirm the N-terminal extension and Arg substitution. LR3, native IGF-I and des(1–3)IGF-I have distinct structures.
What supports this entry?
The reference list is available. A statement-by-statement source check has not been completed for this entry.
These are selected references, not a complete review of the literature. Source checks were assisted by AI and have not received independent expert review.
Research stage, study quality and regulatory status answer different questions. A study card does not establish treatment benefit or approval.
No study details have been extracted for this exact entry yet. This does not mean that no studies exist. Open the references and check the exact material.
How we prepare and correct these entries